An association comprising the following active ingredients is described: a) at least one ceramide, b) at least one saturated fatty acid C12-C22, c) cholesterol d) cholesterol sulfate, in particular for use in restructuring the altered cutaneous barrier following skin diseases wherein said diseases are selected from the class comprising seborrhoeic dermatitis and psoriasis.